EPHRAIM MCDOWELL REG MED CTR — History
CCN 180048 | 3-year financial timeline | COVID resilience: 51/100
🛡️ Public data only — no PHI permitted on this instance.
$208M
Latest Revenue (FY2022)
+8.1%
Revenue CAGR (3yr)
-13.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $178M | $194M | $208M | +7.0% | +8.1% |
| Operating Expenses | $179M | $210M | $236M | +12.8% | +15.1% |
| Operating Margin | -0.6% | -8.0% | -13.8% | -72.6% | +0.0% |
| Net Income | $-1M | $-16M | $-29M | -84.7% | +0.0% |
| Licensed Beds | 143 | 157 | 157 | +0.0% | +4.8% |
| Total Patient Days | 25,901 | 30,865 | 28,882 | -6.4% | +5.6% |
| Medicare Day % | 40% | 33% | 30% | -8.6% | -14.0% |
| Medicaid Day % | 2% | 2% | 2% | -6.8% | +0.8% |
COVID Impact & Recovery
Resilience Score: 51/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +16.9% ($178M → $208M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.1%
This Hospital
+7.6%
State Avg
Latest Margin
-13.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $223M | -20.5% |
| FY2024 (proj) | $238M | -27.1% |
| FY2025 (proj) | $253M | -33.8% |